RecruitingPhase not listedNCT05489705
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Sponsor: Bristol-Myers Squibb
Cooperstown, NY · New York, NY · +57 more sites